Page 7 - Nick Colangelo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nick colangelo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nick Colangelo Today - Breaking & Trending Today

Vericel Corporation (NASDAQ:VCEL) Q2 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by, welcome to Vericel s Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. ....

Jeffrey Cohen , Sam Brodovsky , Eric Burns , Swayampakula Ramakanth , Joe Mara , Nick Colangelo , Ryan Zimmerman , Vericel Corporation , George Sellers Of Stephens Incorporated , Vericel Corp , Call Transcript August , Second Quarter , Vice President , Private Securities Litigation Reform Act , Investor Relations , Chief Executive Officer , Chief Financial Officer , Taiwan This , National Stockpile , George Sellers ,

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Record Second Quarter Total Revenue of $45.9 Million, Representing 24% Growth versus Prior Year MACI Revenue Growth of 27% to $36.3 Million Epicel Revenue Growth of 17% to $9.6 Million Full-Year. ....

United States , United Kingdom , Eric Burns , Matricel Gmb , Nick Colangelo , Vericel Corporation , Mediwound Ltd , Exchange Commission , Record Second Quarter Total Revenue , Revenue Growth , Guidance Raised , Call Today , Matricel Gmbh , Eastern Time , Investor Relations , North American , Annual Report , Quarterly Report , Months Ended June ,

Vericel Reports Second Quarter 2023 Financial Results and

Record Second Quarter Total Revenue of $45.9 Million, Representing 24% Growth versus Prior Year MACI Revenue Growth of 27% to $36.3 Million Epicel. ....

United States , United Kingdom , Eric Burns , Matricel Gmb , Nick Colangelo , Exchange Commission , Mediwound Ltd , Vericel Corporation , Record Second Quarter Total Revenue , Revenue Growth , Guidance Raised , Call Today , Matricel Gmbh , Eastern Time , Investor Relations , North American , Annual Report , Quarterly Report , Months Ended June , Nasdaq Vcel , Vericel Corporation ,

Acer Therapeutics Reports Q1 2023 Financial Results and

U.S. OLPRUVA™ launch progressing ahead of schedule with drug-in-channel now anticipated in mid-June 2023. ....

Jim Denike , Nick Colangelo , Chris Schelling , Exchange Commission , Acer Therapeutics Inc , Gilmartin Group , Development Expenses , Urea Cycle Disorders , Ehlers Danlos Syndrome , Decentralized Study , Event Reduction , Recent Highlights , Annual Meeting , Inherited Metabolic Disorders , Acer Therapeutics , Vasomotor Symptoms , Available Capital , Late May , Collaboration Agreement , Quarterly Report , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Nasdaq Acer , Acer Therapeutics Inc ,

Vericel Corporation (NASDAQ:VCEL) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to Vericel’s First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. ....

United States , Sam Brodovsky , Jeffrey Cohen , Nick Colangelo , Joe Mara , Eric Burns , Sean Lee , Ryan Zimmerman , Ladenburg Thalmann , Vericel Corporation , American Burn Association Annual Meeting , Opt Committee , Clinical Development , Vericel Corp , Call Transcript May , First Quarter , Vice President , Private Securities Litigation Reform Act , Investor Relations , Chief Executive Officer , Chief Financial Officer , George Sellers ,